BioSpace News Archive

Healthcare Management Administrators, Inc. (HMA), a pioneer in self-funded health benefit programs and one of the nation’s largest third-party administrators, today announced Lindsay Harris as the company’s new president.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced new data from PaTH Forward and financial results for the quarter ended June 30, 2020.

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced its participation in the following virtual investor and industry conferences.

Treadwell Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced the initiation of three expansion cohorts in its ongoing Phase 1 study evaluating CFI-402257, a selective and highly potent oral inhibitor of tyrosine threonine kinase (TTK).

Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The Baird 2020 Global Healthcare Conference, being held virtually, which will include a presentation by Mike Shapiro, Chief Financial Officer, on Thursday, September 10, 2020 at 3:10 p.m. EDT. The Morgan Stanley 18 t

Health network at epicenter of pandemic in New Jersey continues to support major innovation in fight against COVID-19 [27-August-2020] HACKENSACK, N.J. , Aug. 27, 2020 /PRNewswire/ -- Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network which treated more COVID-19 patients than any other health system in the state, is now enrollin

Afya Limited, or Afya (Nasdaq: AFYA) today announced it entered into a purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade de Ensino Superior da Amazônia Reunida, or FESAR.

Afya Limited (Nasdaq: AFYA) (“Afya” or the “Company”), the leading medical education group in Brazil, today reported financial and operating results for the three and six-month periods ended June 30, 2020 (second quarter 2020, 2Q20 and first half 2020, respectively

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will present at the Wells Fargo Securities Healthcare Conference on Thursday, September 10, 2020, beginning at 2:00 pm ET. A live and archived webcast of the event will be available from the Investor Relations page of the Company’s website at investor.seaspine.com.

ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today reported financial results for the second quarter ended June 30, 2020, and operational and clinical development highlights